GSK Counsel Recovers $450,000 In Fees For Zofran MDL Defense Costs
BOSTON — The Massachusetts federal judge for the Zofran birth defect multidistrict litigation will allow GlaxoSmithKline LLC (GSK) and its counsel to recover $453,989.18 in costs incurred before a federal appeals...To view the full article, register now.
Already a subscriber? Click here to view full article